BioMarin Pharmaceutical | BMRN - PE Price to Earnings


BioMarin Pharmaceutical reported 19.24 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Acadia Pharmaceuticals 11.61 2.09 Dec/2025
Agios Pharmaceuticals 3.56 0.68 Sep/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amgen 25.31 15.82 Dec/2025
Bayer 5.93 0.68 Sep/2025
Biogen 14.02 4.63 Dec/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Gilead Sciences 15.63 0.08 Dec/2025
Incyte 14.84 2.79 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Moderna 27.22 14.51 Jun/2023
Neurocrine Biosciences 835.47 802.2 Dec/2025
PTC Therapeutics 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Sanofi 15.75 1.53 Dec/2025
Sarepta Therapeutics 27.27 0 Sep/2025
United Therapeutics 17.32 1.62 Dec/2025
Vertex Pharmaceuticals 26.15 2.22 Dec/2025